Procept biorobotics stock.
Analysis of Insider Buy/Sell and Relationship with Stock Price. On November 13, 2023, Morgan Wood sold 25,000 shares of PROCEPT BioRobotics Corp at a price of $32.19 per share. This transaction ...
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued a report on the stock in […]PROCEPT BioRobotics Stock Performance Shares of NASDAQ PRCT opened at $32.82 on Tuesday. The company has a market cap of $1.49 billion, a PE ratio of -14.09 and a beta of 0.63.Procept BioRobotics stock rises as B Riley starts coverage with buy rating, $53 PT SA News Thu, Jun. 23, 2022. Procept BioRobotics gets additional positive coverage policies for prostate gland ...See why PRCT stock is rated a buy. ... Procept BioRobotics: Adding For 2023 Rebound. May 30, 2023 10:19 AM ET PROCEPT BioRobotics Corporation (PRCT) 5 Comments. Off His Game. 1.22K Followers.Mar 10, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently down 17.97% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $29.82. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $22.98 ...
Verdict: PROCEPT BioRobotics lost $1.96 a share on $75 million worth of revenue in FY2022. The current analyst firm consensus has that loss expanding a bit in FY2023 to $2.13 a share even as sales ...Jun 1, 2023 · PROCEPT BioRobotics Corporation: RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net loss $ (25,285) $ (19,184) $ (53,771) $ (36,369) Depreciation and amortization expense 642 717 1,435 1,475 Stock-based compensation expense 5,104 2,676 8,827 ... Nov 30, 2023 · The stock of Procept BioRobotics Corp (PRCT) has gone up by 9.73% for the week, with a 48.65% rise in the past month and a 9.92% rise in the past quarter. The volatility ratio for the week is 4.42%, and the volatility levels for the past 30 days are 5.89% for PRCT. The simple moving […]
Thursday, April 27, 2023 - Procept Biorobotics Corp ( PRCT) reported downside earnings and upside revenues. Procept Biorobotics Corp's earnings came in at an EPS loss of $0.63 per share, 9% lower than estimates for an EPS loss of $0.58 per share. The firm's loss per share expanded by 62% since reporting a loss of $0.39 per share a year ago.
PROCEPT BioRobotics has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500.PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.42 per share a year ago.PROCEPT BioRobotics Corporation (PRCT) Stock Historical Prices & Data - Yahoo Finance S&P 500 (+0.10%) Dow 30 -40.33(-0.12%) Nasdaq +10.56(+0.08%) Russell 2000 -19.08(-1.10%) Crude Oil...PROCEPT BioRobotics has a market cap or net worth of $1.89 billion as of December 1, 2023. Its market cap has decreased by -7.08% in one year. Market Cap 1.89B. ... Formula: Market Cap = Stock Price * Shares Outstanding. Full Definition. Related Stocks. Company Market Cap; IDEAYA Biosciences: 2.04B: Rhythm Pharmaceuticals: …
REDWOOD CITY, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”), a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the closing of its upsized initial public offering of 7,539,400 shares of its ...
PROCEPT BioRobotics Corporation Registered Shs stock has received a consensus rating of buy. The average rating score is and is based on 7 buy ratings, 1 hold ratings, and 0 sell ratings.
Nov 4, 2022 · According to 4 analyst offering 12-month price targets in the last 3 months, PROCEPT BioRobotics has an average price target of $49.75 with a high of $58.00 and a low of $44.00. Below is a summary ... Procept Biorobotics Corp stock performance at a glance. Check Procept Biorobotics Corp’s past financial performance, like revenue or net income, plus the top level …PROCEPT BioRobotics Corporation has completed an IPO in the amount of $163.9 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,556,000The PROCEPT BioRobotics 52-week low stock price is $24.83. What is the market capitalisation of PROCEPT BioRobotics PRCT? As of 01/12/2023 PROCEPT BioRobotics has a market cap of $1.9B.PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. ... Stock Information ...
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.42 per share a year ago.PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued a report on the stock in […]In a report released today, Neil Chatterji from B.Riley Financial reiterated a Buy rating on PROCEPT BioRobotics ( PRCT – Research Report ), with a price target of $60.00. The company’s shares ...28 ก.ย. 2564 ... PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage Policy · Related Stocks · PROCEPT BioRobotics Corporation ...REDWOOD CITY, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...Aug 23, 2021 · Procept BioRobotics Corporation ( NASDAQ: PRCT) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The firm develops and commercializes ... SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by ...
PROCEPT BioRobotics (NASDAQ:PRCT) plans to raise $125 million through an underwritten public offering of shares of its common stock, the company said Tuesday.The underwriters have a 30-day option ...
REDWOOD CITY, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”), a commercial-stage surgical robotics company focused on advancing patient ...Oct 25, 2023 · PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ... Common Stock, $0.00001 par value per share ... On January 9, 2023, PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8 …Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 38.11% so far this month. During the month of November, Procept Biorobotics Corp’s stock price has reached a high of $37.03 and a low of $26.44. Over the last year, Procept Biorobotics Corp has hit prices as high as $47.75 and as low as $24.83 ...This is an initial public offering of shares of common stock of PROCEPT BioRobotics Corporation. We are selling shares of our common stock. Prior to this ...PROCEPT BioRobotics Corporation has completed an IPO in the amount of $163.9 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 6,556,000Procept BioRobotics ( NASDAQ: PRCT) is off 8% in Wednesday morning trading after rival Intuitive Surgical ( NASDAQ: ISRG) announced after the bell Tuesday it received US FDA 510 (k) clearance for ...Inside Procept Biorobotics Corp's 10-K Annual Report: ... compliance with the rules and regulations of the SEC and those of any stock exchange on which our securities are traded, investor relations, and other administrative and professional services expenses, though it may fluctuate from quarter to quarter. ...PROCEPT BioRobotics Corporation (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. ... Stock Market. Commodities Market. Rural News. Industries . Basic Materials. Consumer Goods & Media. Financial. Healthcare. Industrial …
On Wednesday, Procept BioRobotics Corp [NASDAQ: PRCT] rose 9.56% to $37.00. The stock’s lowest price that day was $34.01, but it reached a high of $37.03 in the same session. During the last five days, there has been a surge of approximately 9.73%. Over the course of the year, Procept BioRobotics Corp shares have dropped …
PROCEPT BioRobotics Corporation doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ...
About PRCT. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by ...Apr 27, 2023 · PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $0.39 per share a year ago ... PRCT | Complete PROCEPT BioRobotics Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.NASDAQ: PRCT. $34.69. Nov 29, 2023 10:22 AM EST. Change. +0.92 (+2.72%) Volume. 50,583. Today's Open. $34.34.CharlieAJA/iStock via Getty Images. Procept BioRobotics ( NASDAQ: PRCT) is down 19% in early Thursday afternoon trading after its Q1 2023 financial results missed on the bottom line. The medical ...SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on developing transformative ...Nov 1, 2023 · PROCEPT BioRobotics Corporation RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022: Net loss $ (24,622) $ (22,613) $ (78,393) $ (58,982) Depreciation and amortization expense 1,054 703 2,489 2,178 Stock-based compensation expense 5,326 ... PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with …REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader... Menu icon A vertical stack of three evenly ...Real time Procept BioRobotics (PRCT) stock price quote, stock graph, news & analysis. ... PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the ...
You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Procept wrote in a revised S-1 filing with the U.S. Securities and Exchange Commission that it intends to offer 5.5M shares of its stock at an expected $22-$24/range. The company is also granting ...PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ...Instagram:https://instagram. vanguard extended duration treasury etfsaft stockoreilly stocksbest silver miners stocks Jan 9, 2023 · On January 9, 2023, PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. devon energy dividendbest investment books for beginners 16 ก.ย. 2564 ... ... PROCEPT Journey as a publicly traded company. The company began trading on Nasdaq yesterday after pricing 6.5 6.56000000 shares at $25 per ...REDWOOD CITY, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2022. Recent … jeep wagoneer 2019 Procept BioRobotics ( NASDAQ: PRCT) is off 8% in Wednesday morning trading after rival Intuitive Surgical ( NASDAQ: ISRG) announced after the bell Tuesday it received US FDA 510 (k) clearance for ...PROCEPT BioRobotics Corporation: RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net loss $ (25,285) $ (19,184) $ (53,771) $ (36,369) Depreciation and amortization expense 642 717 1,435 1,475 Stock-based compensation expense 5,104 2,676 8,827 ...